These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3881823)

  • 1. Surface markers in chronic lymphoid leukemias of B cell type.
    Caligaris-Cappio F; Janossy G
    Semin Hematol; 1985 Jan; 22(1):1-12. PubMed ID: 3881823
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N; Derre M; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.
    Campana D; Janossy G; Bofill M; Trejdosiewicz LK; Ma D; Hoffbrand AV; Mason DY; Lebacq AM; Forster HK
    J Immunol; 1985 Mar; 134(3):1524-30. PubMed ID: 3918103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The heterogeneity of human lymphoid leukemias unmasked by immunological studies of membrane markers (author's transl)].
    Seligmann M; Brouet JC; Preud'homme JL
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):339-50. PubMed ID: 303356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of leukemic B-lymphoma cells with the monoclonal antibody anti-Y 29/55].
    Obrecht JP; Gudat F; Forster HK; Albrecht R; Girard MF; Ludwig C; Christen C
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1529-31. PubMed ID: 6975994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface markers in human lymphoid leukaemias.
    Nadkarni JJ; Nadkarni JS; Advani SH
    Indian J Cancer; 1978 Dec; 15(4):43-7. PubMed ID: 317270
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukemias].
    Ugazio AG
    Pediatr Med Chir; 1985; 7(2):177-9. PubMed ID: 2937023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunopathology of lymphatic systemic diseases].
    Huber H; Gattringer C
    Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
    Chen Z; Sigaux F
    Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
    [No Abstract]   [Full Text] [Related]  

  • 15. Aberrant interaction of B-cell lymphocytic leukemia cells with antibody coated polyacrylamide beads.
    Cohen HJ
    Exp Hematol; 1983 Feb; 11(2):162-8. PubMed ID: 6601025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia.
    Belpomme D; Dantchev D; Du Rusquec E; Grandjon D; Huchet R; Pouillart P; Schwarzenberg L; Amiel JL; Mathé G
    Biomedicine; 1974 Mar; 20(2):109-18. PubMed ID: 4605201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lymphoblastic leukemia and immunological markers].
    Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
    Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attempt to characterize lymphocytes of acute lymphoid leukaemia as T or B cells.
    Governa M; Massimo L; Rosanda C; Franchini MI; Tonda GP
    Biomedicine; 1973 Sep; 19(9):384-7. PubMed ID: 4600231
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 20. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.